Immuto Scientific is a biotechnology company that is transforming the way biotherapeutics are discovered. Our proprietary platform utilizes structure-based protein analysis to enable the discovery of next generation therapeutics against challenging target. Immuto Scientific integrates structural mass spectrometry and computational technologies for best-in-class therapeutic discovery and development. Our platform significantly increases the speed and likelihood of identifying highly effective, novel therapeutics against challenging targets including GPCRs, ion channels and other membrane proteins. We partner with pharmaceutical companies to streamline their discovery pipeline and maximize the probability of drug success leading up to clinical trials.